NLRP3 and early-onset autosomal dominant Alzheimer disease: Luteolin has previously been reported to inhibit ER stress-induced neuroinflammation in Alzheimer’s disease mouse model [30] and to suppress lipotoxicity-induced NLRP3 inflammasome activation in macrophages by reducing ER stress [31].